Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 March;63(1) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 March;63(1):62-7

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 March;63(1):62-7

DOI: 10.23736/S1824-4785.17.02793-5

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Prognostic value of PET/CT in patients with lymphoma treated with autologous stem cell transplantation for relapsed/refractory or high risk disease

Piero M. STEFANI 1 , Ugo SALVADORI 1, Michele GOTTARDI 1, Sergio BISSOLI 2, Franca CHIERICHETTI 2, Filippo GHERLINZONI 1


To access the FULL TEXT of this article choose one of the two following options:

PURCHASE THE ARTICLE

You can access the full text of this article (PDF and HTML if available) for 2 days at a price of:  € 45,00.

INDIVIDUAL SUBSCRIBERS/MEMBERS LOGIN


TO SUBSCRIBE

top of page